Oshimi Y - Search Results

1

Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis.

Oshimi K, Oshimi Y, Akahoshi M, Kobayashi Y, Hirai H, Takaku F, Hattori M, Asano S, Kodo H, Nishinarita S, et al. Oshimi K, et al. Among authors: oshimi y. Blood. 1988 Feb;71(2):473-9. Blood. 1988. PMID: 2447984 Free article.

2

Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab' antibody cross-linked to anti-CD10 Fab' antibody.

Oshimi K, Seto T, Oshimi Y, Masuda M, Okumura K, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. Blood. 1991 Mar 1;77(5):1044-9. Blood. 1991. PMID: 1825287 Free article.

3

Perforin gene expression in granular lymphocyte proliferative disorders.

Oshimi K, Shinkai Y, Okumura K, Oshimi Y, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. Blood. 1990 Feb 1;75(3):704-8. Blood. 1990. PMID: 2297572 Free article.

4

Ti (WT31)-negative, CD3-positive, large granular lymphocyte leukemia with nonspecific cytotoxicity.

Oshimi K, Hoshino S, Takahashi M, Akahoshi M, Saito H, Kobayashi Y, Hirai H, Takaku F, Yahagi N, Oshimi Y, et al. Oshimi K, et al. Among authors: oshimi y. Blood. 1988 Apr;71(4):923-31. Blood. 1988. PMID: 2965605 Free article.

5

Differential expression of non-major histocompatibility complex-restricted cytotoxicity in patients with granular lymphocyte-proliferative disorders associated with or unassociated with severe anemia.

Oshimi K, Oshimi Y, Motoji T, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. Am J Hematol. 1992 Jun;40(2):93-7. doi: 10.1002/ajh.2830400204. Am J Hematol. 1992. PMID: 1585924

6

Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.

Oshimi K, Oshimi Y, Yamada O, Wada M, Hara T, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. J Immunol. 1990 May 1;144(9):3312-7. J Immunol. 1990. PMID: 2139452

7

Lysis of lymphoma cells by autologous and allogeneic natural killer cells.

Oshimi K, Oshimi Y, Yamada O, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. Blood. 1985 Mar;65(3):638-43. Blood. 1985. PMID: 2578838 Free article.

8

Characterization of interleukin 2-expanded human peripheral blood lymphocytes: not only NKH-1+-NK cells but also NKH-1+ and NKH-1- T cells are LAK effectors.

Saito H, Oshimi K, Oshimi Y, Mizoguchi H. Saito H, et al. Among authors: oshimi y, oshimi k. Cell Immunol. 1988 Dec;117(2):253-63. doi: 10.1016/0008-8749(88)90116-5. Cell Immunol. 1988. PMID: 3058317

9

Cytotoxicity of interleukin-2-activated lymphocytes for autologous normal blood mononuclear cells.

Oshimi K, Oshimi Y, Saito H, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. J Immunol Methods. 1988 May 9;109(2):161-8. doi: 10.1016/0022-1759(88)90238-4. J Immunol Methods. 1988. PMID: 3258896

10

Cytotoxicity of interleukin 2-activated lymphocytes for leukemia and lymphoma cells.

Oshimi K, Oshimi Y, Akutsu M, Takei Y, Saito H, Okada M, Mizoguchi H. Oshimi K, et al. Among authors: oshimi y. Blood. 1986 Oct;68(4):938-48. Blood. 1986. PMID: 3489494 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters